| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |